Massimo Breccia

Massimo Breccia

Università degli Studi di Roma La Sapienza - Rome / Italy
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1851751
Sapienza University of Rome
person_outline Massimo Breccia's MOST POPULAR ARTICLES
1-) Retinoic acid and arsenic trioxide for acute promyelocytic leukemiaF Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...N engl j Med 369, 111-121, 20131389*2013
2-) The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML expertsExperts in Chronic Myeloid LeukemiaBlood, The Journal of the American Society of Hematology 121 (22), 4439-4442, 20136132013
3-) European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaJL Steegmann, M Baccarani, M Breccia, LF Casado, V García-Gutiérrez, ...Leukemia 30 (8), 1648-1671, 20164342016
4-) Asciminib in chronic myeloid leukemia after ABL kinase inhibitor failureTP Hughes, MJ Mauro, JE Cortes, H Minami, D Rea, DJ DeAngelo, ...New England Journal of Medicine 381 (24), 2315-2326, 20194452019
5-) Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non–high-risk acute promyelocytic leukemia: final results of the …U Platzbecker, G Avvisati, L Cicconi, C Thiede, F Paoloni, M Vignetti, ...Journal of Clinical Oncology 35 (6), 605-612, 20174322017